Antigenics Inc ANTI

$0.00 0.00 (—)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
600
Avg volume
—
Day's range
$0.00 – $0.00
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer. The company was founded in 1994 and is based in Lexington, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
781 674 4400
Website
https://agenusbio.com
Address
3 Forbes Road, Lexington, United States

Latest news

No headlines yet.